Imperagen raises $6.7M seed
Imperagen raised $6.7M in seed funding, announced on 20 May 2026, led by PXN Ventures, with participation from IQ Capital, Northern Gritstone. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly. Imperagen is based in United Kingdom and currently at seed stage, operating in biotech, deeptech.
Northern Gritstone is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Imperagen's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur, Fusion42's AI co-founder, reasons over when benchmarking a founder's own raise against what is closing in the market right now.
Round details
| Company | Imperagen |
| Stage | seed |
| Amount | $6.7M |
| Announced | 20 May 2026 |
| Lead | PXN Ventures |
| Participation | IQ Capital, Northern Gritstone |
| Source | announcement ↗ |
Investing funds on Raise
Explore: Biotech · Seed · United Kingdom
Frequently asked questions
- How much did Imperagen raise?
- Imperagen raised $6.7M in its seed round, announced 2026-05-20.
- Who invested in Imperagen's seed round?
- The round was led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
- What does Imperagen do?
- Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.
Verified 21 May 2026 · Sources: public filings